COFFMAN ROBERT 4
4 · DYNAVAX TECHNOLOGIES CORP · Filed Mar 22, 2018
Insider Transaction Report
Form 4
COFFMAN ROBERT
Chief Scientific Officer & VP
Transactions
- Award
Stock Option (Right to Buy)
2018-03-21+150,000→ 150,000 totalExercise: $18.40Exp: 2025-03-20→ Common Stock (150,000 underlying)
Footnotes (1)
- [F1]50% of this option grant will vest on the second anniversary of the grant date and 50% will vest on the third anniversary of the grant date.